secwatch / observer
8-K filed May 21, 2025, 7:59 PM ET ticker DNA CIK 0001830214
leadership confidence high sentiment neutral materiality 0.65

Ginkgo CFO Dmytruk to resign May 30; CAO Coen appointed CFO

Ginkgo Bioworks Holdings, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark Dmytruk

Chief Financial Officer
DNA · Ginkgo Bioworks Holdings, Inc.
Effective
2025-05-30
Successor
Steven Coen
Filed
May 21, 2025, 7:59 PM ET
Mark Dmytruk, the Company’s Chief Financial Officer and principal financial officer, gave notice on May 19, 2025 of his intention to resign from these roles at the Company on May 30, 2025 to accept a position at another organization
Role change

Steven Coen

Chief Financial Officer
DNA · Ginkgo Bioworks Holdings, Inc.
Effective
2025-05-30
Filed
May 21, 2025, 7:59 PM ET
Steven Coen, CPA, the Company’s Chief Accounting Officer, will become Chief Financial Officer, principal financial officer and principal accounting officer, effective upon Mr. Dmytruk’s resignation

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Dmytruk resigned as Chief Financial Officer at Ginkgo Bioworks Holdings, Inc..

Action
resigned
Role
Chief Financial Officer
Exact text from the filing
Mark Dmytruk, the Company’s Chief Financial Officer and principal financial officer, gave notice on May 19, 2025 of his intention to resign from these roles at the Company on May 30, 2025 to accept a position at another organization
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Coen was appointed as Chief Financial Officer at Ginkgo Bioworks Holdings, Inc..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
Steven Coen, CPA, the Company’s Chief Accounting Officer, will become Chief Financial Officer, principal financial officer and principal accounting officer, effective upon Mr. Dmytruk’s resignation
View on SEC.gov

Ginkgo Bioworks Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001628280-25-027058
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.